Plasma levels of microRNA-145 are associated with severity of coronary artery disease

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Gao, Hai ^a,c   Guddeti, Raviteja Reddy ^b   Matsuzawa, Yasushi ^b   Liu, Li Ping ^d   Su, Li Xiao ^e   Guo, Duo ^f   Nie, Shao Ping ^a,c   Du, Jie ^a,c   Zhang, Ming ^a,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Mayo Clinic   (United States)

^c BEIJING INSTITUTE OF HEART   (China)

^d FIRST HOSPITAL OF TSINGHUA UNIVERSITY   (China)

^e RUTGERS SCHOOL OF PUBLIC HEALTH   (United States)

^f CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 145; MICRORNA; MIRN145 MICRORNA, HUMAN;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD ANALYSIS; BODY MASS; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; THORAX PAIN; BLOOD; DIAGNOSTIC IMAGING; ECHOGRAPHY; GENE EXPRESSION REGULATION; GENETICS; HEART INFARCTION; MIDDLE AGED; SEVERITY OF ILLNESS INDEX;

TAXUS;

CORONARY ARTERY DISEASE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS; SEVERITY OF ILLNESS INDEX; ULTRASONOGRAPHY;

EID: 84929090912     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0123477     Document Type: Article

References (33)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ et al. (2014) Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129: e28-e292. doi: 10.1161/01.cir.0000441139.02102.80 PMID: 24352519
2. Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. (2010) Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med 362: 2155-2165. doi: 10.1056/ NEJMoa0908610 PMID: 20558366
3. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C et al. (2005) Major causes of death among men and women in China. N Engl J Med 353: 1124-1134. PMID: 16162883
4. Ross R (1999) Atherosclerosis - an inflammatory disease. N Engl J Med 340: 115-126. PMID: 9887164
5. Wei Y, Schober A, Weber C (2013) Pathogenic arterial remodeling: the good and bad of microRNAs. Am J Physiol Heart Circ Physiol 304: H1050-1059. doi: 10.1152/ajpheart.00267.2012 PMID: 23396454
6. Heusch G, Libby P, Gersh B, Yellon D, Bohm M, Lopaschuk G et al. (2014) Cardiovascular remodelling in coronary artery disease and heart failure. Lancet.
7. Orr AW, Hastings NE, Blackman BR, Wamhoff BR (2010) Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis. J Vasc Res 47: 168-180. doi: 10.1159/000250095 PMID: 19851078
8. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. PMID: 14744438
9. Sonkoly E, Stahle M, Pivarcsi A (2008) MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18: 131-140. doi: 10.1016/j.semcancer. 2008.01.005 PMID: 18291670
10. Schober A, Thum T, Zernecke A (2012) MicroRNAs in vascular biology - metabolism and atherosclerosis. Thromb Haemost 107: 603-604. doi: 10.1160/TH12-02-0122 PMID: 22398634
11. Schroen B, Heymans S (2012) Small but smart-microRNAs in the centre of inflammatory processes during cardiovascular diseases, the metabolic syndrome, and ageing. Cardiovasc Res 93: 605-613. doi: 10.1093/cvr/cvr268 PMID: 21994347
12. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518. doi: 10.1073/pnas.0804549105 PMID: 18663219
13. Creemers EE, Tijsen AJ, Pinto YM (2012) Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Circ Res 110: 483-495. doi: 10.1161/CIRCRESAHA.111.247452 PMID: 22302755
14. Cordes KR, Sheehy NT, White MP, Berry EC, Morton SU, Muth AN et al. (2009) miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 460: 705-710. doi: 10.1038/nature08195 PMID: 19578358
15. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q et al. (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105: 158-166. doi: 10.1161/CIRCRESAHA.109.197517 PMID: 19542014
16. Pleister A, Selemon H, Elton SM, Elton TS (2013) Circulating miRNAs: novel biomarkers of acute coronary syndrome? Biomark Med 7: 287-305. doi: 10.2217/bmm.13.8 PMID: 23547823
17. Libby P, Theroux P (2005) Pathophysiology of coronary artery disease. Circulation 111: 3481-3488. PMID: 15983262
18. Kaudewitz D, Lee R, Willeit P, McGregor R, Markus HS, Kiechl S et al. (2013) Impact of intravenous heparin on quantification of circulating microRNAs in patients with coronary artery disease. Thromb Haemost 110: 609-615. doi: 10.1160/TH13-05-0368 PMID: 23803974
19. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C et al. (2010) Circulating micro- RNAs in patients with coronary artery disease. Circ Res 107: 677-684. doi: 10.1161/CIRCRESAHA. 109.215566 PMID: 20595655
20. Fisher LD, Kennedy JW, Chaitman BR, Ryan TJ, McCabe C, Weiner D et al. (1981) Diagnostic quantification of CASS (coronary artery surgery study) clinical and exercise test results in determining presence and extent of coronary artery disease. A multivariate approach. Circulation 63: 987-1000. PMID: 7471382
21. (1983) Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Survival data. Circulation 68: 939-950. PMID: 6137292
22. Head SJ, Farooq V, Serruys PW, Kappetein AP (2014) The SYNTAX score and its clinical implications. Heart 100: 169-177. doi: 10.1136/heartjnl-2012-302482 PMID: 23539552
23. Doran AC, Meller N, McNamara CA (2008) Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 28: 812-819. doi: 10.1161/ATVBAHA.107.159327 PMID: 18276911
24. Ishida M, Komori K, Yonemitsu Y, Taguchi K, Onohara T, Sugimachi K. (2001) Immunohistochemical phenotypic alterations of rabbit autologous vein grafts implanted under arterial circulation with or without poor distal runoff-implications of vein graft remodeling. Atherosclerosis 154: 345-354. PMID: 11166767
25. Zhang C (2009) MicroRNA-145 in vascular smooth muscle cell biology: a new therapeutic target for vascular disease. Cell Cycle 8: 3469-3473. PMID: 19829088
26. Albinsson S, Sessa WC (2011) Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics 43: 529-533. doi: 10.1152/physiolgenomics.00146.2010 PMID: 20841497
27. Fichtlscherer S, Zeiher AM, Dimmeler S (2011) Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 31: 2383-2390. doi: 10.1161/ATVBAHA.111.226696 PMID: 22011751
28. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J et al. (2010) Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31: 659-666. doi: 10. 1093/eurheartj/ehq013 PMID: 20159880
29. Li C, Pei F, Zhu X, Duan DD, Zeng C (2012) Circulating microRNAs as novel and sensitive biomarkers of acute myocardial Infarction. Clin Biochem 45: 727-732. doi: 10.1016/j.clinbiochem.2012.04.013 PMID: 22713968
30. Johnson JL (2007) Matrix metalloproteinases: influence on smooth muscle cells and atherosclerotic plaque stability. Expert Rev Cardiovasc Ther 5: 265-282. PMID: 17338671
31. Wei Y, Nazari-Jahantigh M, Neth P, Weber C, Schober A (2013) MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis? Arterioscler Thromb Vasc Biol 33: 449-454. doi: 10.1161/ATVBAHA. 112.300279 PMID: 23324496
32. Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta N et al. (2012) MicroRNA-145 targeted therapy reduces atherosclerosis. Circulation 126: S81-90. PMID: 22965997
33. Sanders I, Holdenrieder S, Walgenbach-Brunagel G, von Ruecker A, Kristiansen G, Muller SC et al. (2012) Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma. Int J Urol 19: 1017-1025. doi: 10.1111/j.1442-2042.2012. 03082.x PMID: 22788411